livongo.comHealthcare / Digital HealthFounded: 2007Funding to Date: $237.65MM
Livongo (formerly Retrofit) is digital healthcare company offering mobile, online and personalized, real-time support for people at risk for or living with chronic conditions.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
04/23/2018 | Series E | $105MM | $xx.xx | $796.49MM | 7wire Ventures, Echo Health Ventures, General Catalyst, Global Health Innovation Fund, Kinnevikmerck, Kleiner Perkins & Draper Fisher Jurvetson Management, M12, Sapphire Ventures, Wanxiang America, Zaffre Investments | |
Price per Share
$xx.xx
Shares Outstanding
12,655,481
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
7wire Ventures, Echo Health Ventures, General Catalyst, Global Health Innovation Fund, Kinnevikmerck, Kleiner Perkins & Draper Fisher Jurvetson Management, M12, Sapphire Ventures, Wanxiang America, Zaffre Investments
|
||||||
03/16/2017 | Series D | $52.5MM | $xx.xx | $320MM | American Investment Holdings, Edb Investments, General Catalyst Partners & Kinnevik, Kleiner Perkins Caufield & Byers, Microsoft Ventures & Undisclosed Existing Investors, Singapore Economic Development Board | |
Price per Share
$xx.xx
Shares Outstanding
11,773,937
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
American Investment Holdings, Edb Investments, General Catalyst Partners & Kinnevik, Kleiner Perkins Caufield & Byers, Microsoft Ventures & Undisclosed Existing Investors, Singapore Economic Development Board
|
||||||
04/22/2016 | Series C | $49.5MM | $xx.xx | $194MM | Cowen Private Investments, Dfj & 7wire Ventures, General Catalyst, Glen Tullman, Healthcare Growth Partners, Kleiner Perkins Caufield & Byers, Merck Global Health Innovation Fund, Sapphire Ventures, Wanxiang America Corporation, Zaffre Investments | |
Price per Share
$xx.xx
Shares Outstanding
14,856,832
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Cowen Private Investments, Dfj & 7wire Ventures, General Catalyst, Glen Tullman, Healthcare Growth Partners, Kleiner Perkins Caufield & Byers, Merck Global Health Innovation Fund, Sapphire Ventures, Wanxiang America Corporation, Zaffre Investments
|
||||||
04/09/2015 | Series B | $20MM | $xx.xx | $87MM | Draper Fisher Jurvetson & General Catalyst Partner, Kleiner Perkins Caufield & Byers | |
Price per Share
$xx.xx
Shares Outstanding
8,934,953
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Draper Fisher Jurvetson & General Catalyst Partner, Kleiner Perkins Caufield & Byers
|
||||||
05/22/2007 | Series A | $10.65MM | $xx.xx | $30MM | General Catalyst Partners & Slow Ventures | |
Price per Share
$xx.xx
Shares Outstanding
10,394,306
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
General Catalyst Partners & Slow Ventures
|